Results 251 to 260 of about 213,305 (310)

Correction: Health technology assessment of surgical robots: a mini-review of a rapidly evolving field. [PDF]

Front Public Health
Zhang T, Zhong Y, Zeng J, Liu GG.
europepmc   +1 more source

Patents, Innovation and Access to New Pharmaceuticals [PDF]

Henry Grabowski
core  

Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements.

BMJ
Sharma T, Kruja K, Årdal C, Lopert R, Mestre-Ferrandiz J, Boselli S, Vogler S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Economic Evaluation of Pharmaceuticals

PharmacoEconomics, 1992
The increased pressures on health care budgets have emphasised the need to demonstrate the value for money from health technologies. Most major pharmaceutical companies have therefore commissioned cost-benefit or cost-effectiveness analysis of their products. There is an assumed analogy between clinical trains, which are required for product licensing,
openaire   +4 more sources

Economic Evaluation of Pharmaceuticals

PharmacoEconomics, 1993
In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals. Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products. In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have ...
Michael Drummond, Frans Rutten, Antonio Brenna, Carlos Gouveia Pinto, Bruno Horisberger, Bengt Jönsson, Claude Le Pen, Joan Rovira, Matthias Graf von der Schulenburg, Harri Sintonen, Koen Torfs   +10 more
openaire   +2 more sources

The Ethics and Economics of Pharmaceutical Pricing

Annual Review of Pharmacology and Toxicology, 2015
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices and find that advances in economic research have increased the sharpness and focus of the ethically based calls to increase access by modifying patent protection and ...
Sara, Parker-Lue, Michael, Santoro, Greg, Koski   +2 more
openaire   +2 more sources

The Economics of Pharmaceutical Policy in Ghana

International Journal of Health Services, 1980
Pharmaceutical expenditure in Ghana accounts for about one-third of the total recurrent costs of the Ministry of Health, but in isolation this figure is a misleading indicator of economic importance. In the primary care sector up to 75–80 percent of the running cost of a health center may be accounted for by pharmaceuticals, and because the Ghanaian ...
A, Barnett, A L, Creese, E C, Ayivor
openaire   +2 more sources

Economic analysis and pharmaceutical policy

Anaesthesia, 1995
Summary Economic evaluation, a comparative analysis of alternative actions in terms of costs and consequences, allows rational decisions to be made concerning the deployment of resources (people, time, equipment, facilities and knowledge).
openaire   +2 more sources

The Economics of Pharmaceutical Supply in Tanzania

International Journal of Health Services, 1980
This paper analyzes the patterns of purchasing, distribution, and utilization of pharmaceuticals currently found in Tanzania, an underdeveloped country in Africa. Like other nations in the Third World, Tanzania offers the prospect of a rapidly expanding market for the multinational pharmaceutical industry.
openaire   +2 more sources

Economic evaluation for pharmaceuticals in Germany

The European Journal of Health Economics, 2007
Springer-Verlag 2007 With the new legislation in Germany, cost-benefit assessment can be used to stipulate maximum reimbursement amounts for pharmaceuticals. According to the law, the Institute for Quality and Efficiency in the Health Care Sector (IQWiG) can be commissioned by the Federal Joint Committee (G-BA) and the Ministry of Health with the ...
openaire   +2 more sources